Access Resources
7251 - 7300 of 7616 Results
Title
Year
-
RESTRICTEDTitle: PD biomarkers—use of α-synuclein reaches new levelsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 6Start Page: 308End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2011.66Best OA location URL: https://europepmc.org/articles/pmc4043344?pdf=renderCitation Count: 1
-
RESTRICTEDTitle: Group patient visits for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 18Start Page: 1542End Page: 1547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194badBest OA location URL: https://europepmc.org/articles/pmc3100128?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://europepmc.org/articles/pmc3154995?pdf=renderCitation Count: 19
-
RESTRICTEDTitle: Abnormal calcium homeostasis and protein folding stress at the ERJournal Name: Communicative & Integrative BiologyPublisher: Informa UK LimitedVol: 4Issue #: 3Start Page: 258End Page: 261Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.4161/cib.4.3.15019Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/cib.4.3.15019?needAccess=true&role=buttonCitation Count: 34
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats2011RESTRICTEDTitle: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 6Start Page: 861End Page: 868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032Best OA location URL: https://europepmc.org/articles/pmc3133531?pdf=renderCitation Count: 69
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures2011RESTRICTEDTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Best OA location URL: https://europepmc.org/articles/pmc3376651?pdf=renderCitation Count: 232
- Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease2011RESTRICTEDTitle: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 122Issue #: 1Start Page: 49End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1Best OA location URL: https://europepmc.org/articles/pmc3362487?pdf=renderCitation Count: 78
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011RESTRICTEDTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Best OA location URL: https://europepmc.org/articles/pmc3078809Citation Count: 66
-
RESTRICTEDTitle: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 4Issue #: 1Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.11001Best OA location URL: https://doi.org/10.14802/jmd.11001Citation Count: 15
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications2011RESTRICTEDTitle: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applicationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1386End Page: 1397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23737Best OA location URL: https://europepmc.org/articles/pmc3150637?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Priorities in Parkinson's disease researchJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 10Issue #: 5Start Page: 377End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrd3430Citation Count: 369
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 35
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011RESTRICTEDTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://europepmc.org/articles/pmc3142314?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6Journal Name: Annals of Human GeneticsPublisher: WileyVol: 75Issue #: 3Start Page: 351End Page: 358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.xBest OA location URL: https://europepmc.org/articles/pmc3077806?pdf=renderCitation Count: 10
- Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure2011RESTRICTEDTitle: Reduced uptake of [ 18 F]FDOPA PET in asymptomatic welders with occupational manganese exposureJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 15Start Page: 1296End Page: 1301Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182152830Best OA location URL: https://europepmc.org/articles/pmc3090062?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://europepmc.org/articles/pmc3160280?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: S-Nitrosylation of ApoE in Alzheimer’s DiseaseJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 50Issue #: 17Start Page: 3405End Page: 3407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi200266vBest OA location URL: https://europepmc.org/articles/pmc3082618?pdf=renderCitation Count: 37
-
RESTRICTEDTitle: Methylphenidate for gait impairment in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 14Start Page: 1256End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182143537Best OA location URL: https://europepmc.org/articles/pmc3068005?pdf=renderCitation Count: 83
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy2011RESTRICTEDTitle: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 178Issue #: 4Start Page: 1509End Page: 1516Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006Best OA location URL: http://ajp.amjpathol.org/article/S0002944011000575/pdfCitation Count: 102
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease2011RESTRICTEDTitle: Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 33Issue #: 9Start Page: 1598End Page: 1610Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2011.07660.xBest OA location URL: https://europepmc.org/articles/pmc3086951?pdf=renderCitation Count: 111
-
RESTRICTEDTitle: Molecular insights into Parkinson's diseaseJournal Name: F1000 Medicine ReportsPublisher: Faculty Opinions LtdVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3410/m3-7Best OA location URL: https://connect.h1.co/prime/reports/m/3/7/pdfCitation Count: 46
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011RESTRICTEDTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 104
-
RESTRICTEDTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://europepmc.org/articles/pmc3140626?pdf=renderCitation Count: 7
- Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adults2011RESTRICTEDTitle: Tremor severity and age: A cross‐sectional, population‐based study of 2,524 young and midlife normal adultsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1515End Page: 1520Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23674Best OA location URL: https://europepmc.org/articles/pmc5927551?pdf=renderCitation Count: 10
-
RESTRICTEDTitle: Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 7Issue #: 4Start Page: 436End Page: 444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2010.08.228Best OA location URL: https://europepmc.org/articles/pmc3117084?pdf=renderCitation Count: 106
-
RESTRICTEDTitle: Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 5Start Page: 778End Page: 792Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.22321Best OA location URL: https://europepmc.org/articles/pmc3082599?pdf=renderCitation Count: 86
-
RESTRICTEDTitle: Use of ibuprofen and risk of Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 10Start Page: 863End Page: 869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820f2d79Best OA location URL: https://europepmc.org/articles/pmc3059148?pdf=renderCitation Count: 280
-
RESTRICTEDTitle: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Journal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 203End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nchembio.538Best OA location URL: https://europepmc.org/articles/pmc3287420?pdf=renderCitation Count: 381
- A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions2011RESTRICTEDTitle: A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusionsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 46Issue #: 3Start Page: 597End Page: 606Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.12.011Best OA location URL: https://europepmc.org/articles/pmc3046337?pdf=renderCitation Count: 66
-
RESTRICTEDTitle: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 41Issue #: 3Start Page: 706End Page: 716Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008Best OA location URL: https://europepmc.org/articles/pmc3059106?pdf=renderCitation Count: 173
-
RESTRICTEDTitle: Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 570End Page: 580Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.22311Best OA location URL: https://europepmc.org/articles/pmc3117674?pdf=renderCitation Count: 377
- Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration2011RESTRICTEDTitle: Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 228Issue #: 1Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.12.018Best OA location URL: https://europepmc.org/articles/pmc3041148?pdf=renderCitation Count: 65
- Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients2011RESTRICTEDTitle: Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 3Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci43871Best OA location URL: http://www.jci.org/articles/view/43871/files/pdfCitation Count: 141
-
RESTRICTEDTitle: Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 9Start Page: 774End Page: 780Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820ee1bbBest OA location URL: https://europepmc.org/articles/pmc3053335?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Mutational analysis of parkin and PINK1 in multiple system atrophyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 32Issue #: 3Start Page: 548.e5End Page: 548.e7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2009.11.020Best OA location URL: https://europepmc.org/articles/pmc3934211?pdf=renderCitation Count: 16
-
RESTRICTEDTitle: Personality Characteristics and Motor Skills Attributed to Occupations in Parkinson DiseaseJournal Name: Cognitive and Behavioral NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 24Issue #: 1Start Page: 18End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnn.0b013e318218c5ebBest OA location URL: https://europepmc.org/articles/pmc3656654?pdf=renderCitation Count: 16
-
RESTRICTEDTitle: White matter lesions in Parkinson diseaseJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 229End Page: 236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2011.21Best OA location URL: https://europepmc.org/articles/pmc3739056?pdf=renderCitation Count: 176
- Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu42011RESTRICTEDTitle: Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu4Journal Name: ACS Combinatorial SciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 2Start Page: 159End Page: 165Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/co1000508Best OA location URL: https://europepmc.org/articles/pmc3057427?pdf=renderCitation Count: 6
-
RESTRICTEDTitle: In vivo demonstration that α-synuclein oligomers are toxicJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 10Start Page: 4194End Page: 4199Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1100976108Best OA location URL: https://europepmc.org/articles/pmc3053976?pdf=renderCitation Count: 1279
-
RESTRICTEDTitle: MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 7Start Page: 670End Page: 672Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820c30c1Best OA location URL: https://europepmc.org/articles/pmc3053340?pdf=renderCitation Count: 67
-
RESTRICTEDTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://europepmc.org/articles/pmc3082617?pdf=renderCitation Count: 31
- Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms2011RESTRICTEDTitle: Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanismsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 121Issue #: 6Start Page: 705End Page: 719Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00401-011-0806-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-011-0806-2.pdfCitation Count: 49
- Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats2011RESTRICTEDTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://europepmc.org/articles/pmc3820002?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 5Start Page: 467End Page: 474Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820a0e3bBest OA location URL: https://europepmc.org/articles/pmc3034409?pdf=renderCitation Count: 213
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells2011RESTRICTEDTitle: α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cellsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 2Start Page: 715End Page: 725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci43366Best OA location URL: http://www.jci.org/articles/view/43366/files/pdfCitation Count: 737
-
RESTRICTEDTitle: Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 18Issue #: 5Start Page: 756End Page: 765Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2011.03353.xBest OA location URL: https://europepmc.org/articles/pmc3556904?pdf=renderCitation Count: 96
-
RESTRICTEDTitle: Essential tremor and Parkinson's disease: Lack of a linkJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 3Start Page: 372End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23509Best OA location URL: https://europepmc.org/articles/pmc3070808?pdf=renderCitation Count: 55
-
RESTRICTEDTitle: From reinforcement learning models to psychiatric and neurological disordersJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 2Start Page: 154End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2723Best OA location URL: https://europepmc.org/articles/pmc4408000?pdf=renderCitation Count: 637
-
RESTRICTEDTitle: Olfaction in Parkin heterozygotes and compound heterozygotesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 4Start Page: 319End Page: 326Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820882aaBest OA location URL: https://europepmc.org/articles/pmc3034420?pdf=renderCitation Count: 47
- Cyclin-G-associated kinase modifies -synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study2011RESTRICTEDTitle: Cyclin-G-associated kinase modifies -synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD StudyJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 8Start Page: 1478End Page: 1487Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddr026Best OA location URL: https://europepmc.org/articles/pmc3063983?pdf=renderCitation Count: 61